Enveric Biosciences (ENVB) Short Interest Ratio & Short Volume

Short interest is the volume of Enveric Biosciences shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 254,900 shares of ENVB short. 4.23% of Enveric Biosciences' shares are currently sold short. Learn More on Enveric Biosciences' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.23% of Enveric Biosciences' floating shares are currently sold short.

Enveric Biosciences saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 254,900 shares, an increase of 69.5% from the previous total of 150,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Enveric Biosciences currently has issued a total of 7,290,000 shares. Some of Enveric Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Enveric Biosciences currently has a public float of 6,030,000 shares.

4.23% of Enveric Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Enveric Biosciences: Shuttle Pharmaceuticals Holdings, Inc. (0.72%), Sunshine Biopharma, Inc. (0.77%), Ainos, Inc. (4.81%), Cadrenal Therapeutics, Inc. (0.50%), Tenax Therapeutics, Inc. (2.62%), Xenetic Biosciences Inc (0.14%), First Wave BioPharma, Inc. (3.04%), Trevena, Inc. (0.63%), Protagenic Therapeutics, Inc. (0.32%), Chemomab Therapeutics Ltd. (1.87%),

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

Short selling ENVB is an investing strategy that aims to generate trading profit from Enveric Biosciences as its price is falling. ENVB shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Enveric Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENVB, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENVB, twice per month. The most recent reporting period available is March, 31 2024.